Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: Studies in dopamine receptor knockout mice

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 294, Issue 2, 2008, Pages

  Zeng, Chunyu ^a   Armando, Ines ^b   Luo, Yingjin ^b   Eisner, Gilbert M ^b   Felder, Robin A ^c   Jose, Pedro A ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Dopamine receptor; Knockout mice

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; CATECHOLAMINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE RECEPTOR; ENDOTHELIN; OXYTOCIN; PROLACTIN; PROOPIOMELANOCORTIN; REACTIVE OXYGEN METABOLITE; RENIN; VASOPRESSIN;

DISEASE MODEL; EPITHELIUM CELL; HUMAN; HYPERTENSION; KNOCKOUT MOUSE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SODIUM TRANSPORT;

ANIMALS; BLOOD PRESSURE; DOPAMINE; HYPERTENSION; MICE; MICE, KNOCKOUT; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RECEPTORS, DOPAMINE D4; RECEPTORS, DOPAMINE D5;

EID: 39149118915     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01036.2007     Document Type: Review

References (280)

1. Abell TJ, Richard AM, Ikram H, Espiner EA, Yandle Y. Atrial natriuretic factor inhibits proliferation of vascular smooth muscle cells stimulated by platelet-derived growth factor. Biochem Biophys Res Commun 160: 1392-1396, 1989.
2. Accili D, Fishburn CS, Drago J, Steiner H, Lachowicz JE, Park BH, Gauda EB, Lee EJ, Cool MH, Sibley DR, Gerfen CR, Westphal H, Fuchs S. A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. Proc Natl Acad Sci USA 93: 1945-1949, 1996.
3. Agnoli GC, Borgatti R, Cacciari M, Garutti C, Ikonomu E, Lenzi P. Antagonistic effects of sulpiride-racemic and enantiomers-on renal response to low-dose dopamine infusion in normal women. Nephron 51: 491-498, 1989.
4. Agnoli GC, Cacciari M, Garutti C, Ikonomu E, Lenzi P, Marchetti G. Effects of extracellular fluid volume changes on renal response to low-dose dopamine infusion in normal women. Clin Physiol 7: 465-479, 1987.
5. Albrecht FE, Drago J, Felder RA, Printz MP, Eisner GM, Robillard JE, Sibley DR, Westphal HJ, Jose PA. Role of the D1A dopamine receptor in the pathogenesis of genetic hypertension. J Clin Invest 97: 2283-2288, 1996.
6. Allayee H, de Bruin TW, Michelle Dominguez K, Cheng LS, Ipp E, Cantor RM, Krass KL, Keulen ET, Aouizerat BE, Lusis AJ, Rotter JI. Genome scan for blood pressure in Dutch dyslipidemic families reveals linkage to a locus on chromosome 4p. Hypertension 38: 773-778, 2001.
7. Amenta F. Light microscope autoradiography of peripheral dopamine receptor subtypes. Clin Exp Hypertens 19: 27-41, 1997.
8. Amenta F, Barili P, Bronzetti E, Felici L, Mignini F, Ricci A. Localization of dopamine receptor subtypes in systemic arteries. Clin Exp Hypertens 22: 277-288, 2000.
9. 1-like receptor subtypes in the rat kidney: a microanatomical study. Clin Exp Hypertens 21: 17-23, 1999.
10. +-2Cl- cotransport in rat medullary thick ascending limb by dopamine. Am J Physiol Regul Integr Comp Physiol 271: R1561-R1567, 1996.
11. +-ATPase activity in rat proximal convoluted tubule segments. Am J Physiol Renal Fluid Electrolyte Physiol 252: F39-F45, 1987.
12. Aperia A, Eklof AC, Holtback U, Nowicki S, Sundelof M, Greengard P. The renal dopamine system. Adv Pharmacol 42: 870-873, 1998.
13. Armando I, Wang X, Pascua AM, Villar VM, Luo Y, Jones JE, Asico L, Escano C, Jose PA. Regulation of Renal NADPH Oxidase and Inflammation by Dopamine D2 Receptors. Orlando, FL: American Heart Association Scientific Sessions, November 2007.
14. 2 receptor-deficient mice. Hypertension 49: 672-678, 2007.
15. +-ATPase in rat renal proximal tubules. Eur J Pharmacol 411: 61-66, 2001.
16. Asghar M, Hussain T, Lokhandwala MF. Overexpression of PKC-βI and -δ contributes to higher PKC activity in the proximal tubules of old Fischer 344 rats. Am J Physiol Renal Physiol 285: F1100-F1107, 2003.
17. 3 receptor gene produces renin-dependent hypertension. J Clin Invest 102: 493-498, 1998.
18. 2-receptor antagonists. Regul Pept 127: 151-157, 2005.
19. 4 receptor-mediated presynaptic inhibition of GABAergic transmission in the rat supraoptic nucleus. J Neurophysiol 90: 559-565, 2003.
20. +/phosphate cotransporter NaPi-IIa in mouse kidney and OK cells. Am J Physiol Renal Physiol 288: F740-F747, 2005.
21. Bacic D, Kaissling B, McLeroy P, Zou L, Baum M, Moe OW. Dopamine acutely decreases apical membrane Na/H exchanger NHE3 protein in mouse renal proximal tubule. Kidney Int 64: 2133-2141, 2003.
22. Baik JH, Picetti R, Saiardi A, Thiriet G, Dierich A, Depaulis A, Le Meur M, Borrelli E. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature 377: 424-428, 1995.
23. Baines AD, Drangova R. Does dopamine use several signal pathways to inhibit Na-Pi transport in OK cells? J Am Soc Nephrol 9: 1604-1612, 1998.
24. Banday AA, Hussain T, Lokhandwala MF. Renal dopamine D1 receptor dysfunction is acquired and not inherited in obese Zucker rats. Am J Physiol Renal Physiol 287: F109-F116, 2004.
25. 2-like receptors in the kidney of spontaneously hypertensive rats: a radioligand binding assay and light microscope autoradiography study. J Auton Pharmacol 18: 89-97, 1998.
26. Barili P, Ricci A, Baldoni E, Mignini F, Amenta F. Pharmacological characterizsation and autoradiographic localisation of a putative dopamine D3 receptor in the rat kidney. Eur J Pharmacol 338: 89-95, 1997.
27. Barili P, Sabbatini M, Soares-da-Silva P, Amenta F. The peripheral dopaminergic system: morphological analysis, functional and clinical applications. Ital J Anat Embryol 107: 145-167, 2002.
28. Bastianetto S, Danik M, Mennicken F, Williams S, Quirion R. Prototypical antipsychotic drugs protect hippocampal neuronal cultures against cell death induced by growth medium deprivation. BMC Neurosci 7: 28, 2006.
29. Beazely MA, Watts VJ. Activation of a novel PKC isoform synergistically enhances D2L dopamine receptor-mediated sensitization of adenylate cyclase type 6. Cell Signal 17: 647-653, 2005.
30. Beige J, Bellmann A, Sharma AM, Gessner R. Ethnic origin determines the impact of genetic variants in dopamine receptor gene (DRD1) concerning essential hypertension. Am J Hypertens 17: 1184-1187, 2004.
31. 1-like receptor. Nephrol Dial Transplant 14: 581-587, 1999.
32. 4 dopamine receptor-deficient mice. Hypertension 47: 288-295, 2006.
33. Bek MJ, Zheng S, Xu J, Yamaguchi I, Asico LD, Sun XG, Jose PA. Differential expression of adenylyl cyclases in the rat nephron. Kidney Int 60: 890-899, 2001.
34. +-ATPase activity requires simultaneous activation of DA1 and DA2 receptors. Am J Physiol Renal Fluid Electrolyte Physiol 259: F924-F928, 1990.
35. 2 dopamine receptor synergism. Nature 347: 386-388, 1990.
36. Bianchi P, Seguelas MH, Parini A, Cambon C. Activation of proapoptotic cascade by dopamine in renal epithelial cells is fully dependent on hydrogen peroxide generation by monoamine oxidases. J Am Soc Nephrol 14: 855-862, 2003.
37. Bouvier M. Oligomerization of G-protein-coupled transmitter receptors. Nat Rev Neurosci 2: 274-286, 2001.
38. 1 receptors to the plasma membrane. Proc Natl Acad Sci USA 95: 5573-5578, 1998.
39. Bughi S, Horton R, Antonipillai I, Manoogian C, Ehrlich L, Nadler J. Comparison of dopamine and fenoldopam effects on renal blood flow and prostacyclin excretion in normal and essential hypertensive subjects. J Clin Endocrinol Metab 69: 1116-1121, 1989.
40. 2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. J Biol Chem 278: 46741-46749, 2003.
41. 3 dopamine receptor agonists. Parkinsonism Relat Disord 7: 213-223, 2001.
42. Carey RM, Siragy HM, Ragsdale NV, Howell NL, Felder RA, Peach MJ, Chevalier RL. Dopamine-1 and dopamine-2 mechanisms in the control of renal function. Am J Hypertens 3: 59S-63S, 1990.
43. Chatziantoniou C, Ruan X, Arendshorst WJ. Interactions of cAMP-mediated vasodilators with angiotensin II in rat kidney during hypertension. Am J Physiol Renal Fluid Electrolyte Physiol 265: F845-F852, 1993.
44. 2 receptors in rat heart and coronary vessels. Clin Exp Pharmacol Physiol 29: 412-418, 2002.
45. Chen C, Beach RE, Lokhandwala MF. Dopamine fails to inhibit renal tubular sodium pump in hypertensive rats. Hypertension 21: 364-372, 1993.
46. Chen C, Lokhandwala MF. Potentiation by enalaprilat of fenoldopamevoked natriuresis is due to blockade of intrarenal production of angiotensin-II in rats. Naunyn Schmiedebergs Arch Pharmacol 352: 194-200, 1995.
47. Chen CJ, Lokhandwala MF. An impairment of renal tubular DA-1 receptor function as the causative factor for diminished natriuresis to volume expansion in spontaneously hypertensive rats. Clin Exp Hypertens 14: 615-628, 1992.
48. Cheng HF, Becker BN, Burns KD, Harris RC. Angiotensin II upregulates type-1 angiotensin II receptors in renal proximal tubule. J Clin Invest 95: 2012-2019, 1995.
49. Cheng HF, Becker BN, Harris RC. Dopamine decreases expression of type-1 angiotensin II receptors in renal proximal tubule. J Clin Invest 97: 2745-2752, 1996.
50. Cho DI, Quan W, Oak MH, Choi HJ, Lee KY, Kim KM. Functional interaction between dopamine receptor subtypes for the regulation of c-fos expression. Biochem Biophys Res Commun 357: 1113-1138, 2007.
51. Cosentino M, Rasini E, Colombo C, Marino F, Blandini F, Ferrari M, Samuele A, Lecchini S, Nappi G, Frigo G. Dopaminergic modulation of oxidative stress and apoptosis in human peripheral blood lymphocytes: evidence for a D1-like receptor-dependent protective effect. Free Radic Biol Med 36: 1233-12340, 2004.
52. Cravchik A, Gejman PV. Functional analysis of the human D5 dopamine receptor missense and nonsense variants: differences in dopamine binding affinities. Pharmacogenetics 9: 199-206, 1999.
53. Crowley SD, Gurley SB, Herrera MJ, Ruiz P, Griffiths R, Kumar AP, Kim HS, Smithies O, Le TH, Coffman TM. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci USA 103: 17985-17990, 2006.
54. DiBona GF. Sympathetic nervous system and the kidney in hypertension. Curr Opin Nephrol Hypertens 11: 197-200, 2002.
55. Dickson ME, Sigmund CD. Genetic basis of hypertension: revisiting angiotensinogen. Hypertension 48: 14-20, 2006.
56. 2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. J Neurochem 72: 148-156, 1999.
57. +-ATPase alpha-subunit is essential for AP-2 binding and clathrin-dependent endocytosis. J Biol Chem 277: 17108-17111, 2002.
58. 1A dopamine receptors. Proc Natl Acad Sci USA 91: 12564-12568, 1994.
59. Dunah AW, Standaert DG. Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane. J Neurosci 21: 5546-5558, 2001.
60. 2 receptors in the plasma membrane. Biochemistry 45: 8751-8759, 2006.
61. Edvinsson L, McCulloch J, Sharkey J. Vasomotor responses of cerebral arterioles in situ to putative dopamine receptor agonists. Br J Pharmacol 85: 403-410, 1985.
62. Edwards RM, Brooks DP. Dopamine inhibits vasopressin action in the rat inner medullary collecting duct via 2-adrenoceptors. J Pharmacol Exp Ther 298: 1001-1006, 2001.
63. +-ATPase activity. FEBS Lett 456: 45-48, 1999.
64. + regulates dopamine and angiotensin II receptors availability at the plasma membrane and their cellular responses in renal epithelia. J Biol Chem 278: 28719-28726, 2003.
65. Efendiev R, Cinelli AR, Leibiger IB, Bertorello AM, Pedemonte CH. FRET analysis reveals a critical conformational change within the Na,K-ATPase alpha1 subunit N-terminus during GPCR-dependent endocytosis. FEBS Lett 580: 5067-5070, 2006.
66. Eklof AC. The natriuretic response to a dopamine DA1 agonist requires endogenous activation of dopamine DA2 receptors. Acta Physiol Scand 160: 311-314, 1997.
67. 3 dopamine receptor activates phospholipase D through a pertussis toxin-insensitive pathway. Neurosci Lett 371: 34-39, 2004.
68. Felder CC, Campbell T, Albrecht F, Jose PA. Dopamine inhibits Na -H exchanger activity in renal BBMV by stimulation of adenylate cyclase. Am J Physiol Renal Fluid Electrolyte Physiol 259: F297-F303, 1990.
69. Felder CC, Jose PA, Axelrod J. The dopamine-1 agonist, SKF 82526, stimulates phospholipase-C activity independent of adenylate cyclase. J Pharmacol Exp Ther 248: 171-175, 1989.
70. Felder RA, Blecher M, Eisner GM, Jose PA. Cortical tubular and glomerular dopamine receptors in the rat kidney. Am J Physiol Renal Fluid Electrolyte Physiol 246: F557-F568, 1984.
71. Felder RA, Jose PA. Dopamine1 receptors in rat kidneys identified with 125I-Sch 23982. Am J Physiol Renal Fluid Electrolyte Physiol 255: F970-F976, 1988.
72. Felder RA, Kinoshita S, Ohbu K, Mouradian MM, Sibley DR, Monsma FJ Jr, Minowa T, Minowa MT, Canessa LM, Jose PA. Organ specificity of the dopamine1 receptor/adenylyl cyclase coupling defect in spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 264: R726-R732, 1993.
73. Felder RA, Seikaly MG, Cody P, Eisner GM, Jose PA. Attenuated renal response to dopaminergic drugs in spontaneously hypertensive rats. Hypertension 15: 560-569, 1990.
74. 1 dopamine receptor (Abstract). Hypertension 42: 438A, 2003.
75. 2 receptor-receptor heteromers. Targets for neuro-psychiatric disorders. Parkinsonism Relat Disord 10: 265-271, 2004.
76. Fink GD. Hypothesis: the systemic circulation as a regulated free-market economy. A new approach for understanding the long-term control of blood pressure. Clin Exp Pharmacol Physiol 32: 377-383, 2005.
77. Fiorentini C, Gardoni F, Spano P, Di Luca M, Missale C. Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-D-aspartate receptors. J Biol Chem 278: 20196-20202, 2003.
78. Fryckstedt J, Meister B, Aperia A. Control of electrolyte transport in the kidney through a dopamine- and cAMP-regulated phosphoprotein, DARPP-32. J Auton Pharmacol 12: 183-189, 1992.
79. 2 subfamily of dopamine receptor genes in kidney. Am J Physiol Renal Fluid Electrolyte Physiol 266: F646-F650, 1994.
80. Gines S, Hillion J, Torvinen M, Le Crom S, Casado V, Canela EI, Rondin S, Lew JY, Watson S, Zoli M, Agnati LF, Verniera P, Lluis C, Ferre S, Fuxe K, Franco R. Dopamine and adenosine A1 receptors form functionally interacting heterotrimeric complexes. Proc Natl Acad Sci USA 97: 8606-8611, 2000.
81. Glickstein SB, Schmauss C. Dopamine receptor functions: lessons from knockout mice [corrected]. Pharmacol Ther 91: 63-83, 2001.
82. + channels. Am J Physiol Renal Physiol 283: F114-F123, 2002.
83. 2-like receptors in the guinea pig heart. Can J Physiol Pharmacol 80: 578-587, 2002.
84. Granger JP, Schnackenberg CG. Renal mechanisms of angiotensin II-induced hypertension. Semin Nephrol 20: 417-425, 2000.
85. Grider J, Kilpatrick E, Ott C, Jackson B. Effect of dopamine on NaCl transport in the medullary thick ascending limb of the rat. Eur J Pharmacol 342: 281-284, 1998.
86. 1 receptor-dependent inhibition of NaCl transport in the rat thick ascending limb: mechanism of action. Eur J Pharmacol 473: 185-190, 2003.
87. Hall JE. The kidney, hypertension, and obesity. Hypertension 41: 625-633, 2003.
88. 2+ uptake through cAMP, PLC/PKC, and MAPKs in renal proximal tubule cells. J Cell Physiol 211: 486-494, 2007.
89. 1 receptor and ACE binding in ANG II-induced hypertensive rats. Am J Physiol Renal Physiol 282: F19-F25, 2002.
90. Hedge SS, Ricci A, Amenta F, Lokhandwala MF. Evidence from functional and autoradiographic studies for the presence of tubular dopamine-1 receptors and their involvement in the renal effects of fenoldopam. J Pharmacol Exp Ther 251: 1237-1245, 1989.
91. 3 receptor causes a shift from cAMP related to PGE2 related signal transduction mechanisms in transfected CHO cells. J Med Genet 41: 867-871, 2004.
92. Hillion J, Canals M, Torvinen M, Casado V, Scott R, Terasmaa A, Hansson A, Watson S, Olah ME, Mallol J. Coaggregation, cointernalization and codesensitization of adenosine A2A receptors and dopamine D2 receptors. J Biol Chem 277: 18091-18097, 2002.
93. Hollon TR, Bek MJ, Lachowicz JE, Ariano MA, Mezey E, Ramachandran R, Wersinger SR, Soares-da-Silva P, Liu ZF, Grinberg A, Drago J, Young WS 3rd, Westphal H, Jose PA, Sibley DR. Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive. J Neurosci 22: 10801-10810, 2002.
94. 5 receptor null mutant mice. Behav Neurosci 115: 1129-1144, 2001.
95. Holmes A, Lachowicz JE, Sibley DR. Phenotypic analysis of dopamine receptor knockout mice; recent insights into the functional specificity of dopamine receptor subtypes. Neuropharmacology 47: 1117-1134, 2004.
96. + ATPase activity through protein kinase A. Mol Pharmacol 43: 281-285, 1993.
97. + exchanger (NHE3) endocytosis via clathrin-coated vesicles: dependence on protein kinase A-mediated NHE3 phosphorylation. J Biol Chem 276: 26906-26915, 2001.
98. 1 receptors in rat kidney with [3H]Sch 23390. Am J Physiol Renal Fluid Electrolyte Physiol 257: F414-F423, 1989.
99. Hussain T, Abdul-Wahab R, Kotak DK, Lokhandwala MF. Bromocriptine regulates angiotensin II response on sodium pump in proximal tubules. Hypertension 32: 1054-1059, 1998.
100. +-ATPase in renal proximal tubules via the cAMP pathway. Eur J Pharmacol 321: 259-263, 1997.
101. +-ATPase in kidney of spontaneously hypertensive rats. Clin Exp Hypertens 18: 963-974, 1996.
102. Hussain T, Lokhandwala MF. Dopamine-1 receptor G-protein coupling and the involvement of phospholipase A2 in dopamine-1 receptor mediated cellular signaling mechanisms in the proximal tubules of SHR. Clin Exp Hypertens 19: 131-140, 1997.
103. q/11 proteins in spontaneously hypertensive rats. Am J Physiol Renal Physiol 272: F339-F346, 1997.
104. Hussain T, Lokhandwala MF. Renal dopamine receptors and hypertension. Exp Biol Med (Maywood) 228: 134-142, 2003.
105. 4 receptors inhibits oxidative stress-induced nerve cell death. J Neurosci 21: 6069-6076, 2001.
106. 2-receptor agonist and antagonist drugs on somatostatin binding, inhibition of adenylyl cyclase activity and accumulation of inositol 1,4,5-trisphosphate in the rat striatum. Brain Res Mol Brain Res 47: 99-107, 1997.
107. 5 receptors. J Neurochem 95: 1387-1400, 2005.
108. James K, Weitzel LR, Engelman CD, Zerbe G, Norris JM; Framingham Heart Study. Genome scan linkage results for longitudinal systolic blood pressure phenotypes in subjects from the Framingham Heart Study. BMC Genet 4, Suppl 1: S83, 2003.
109. 1 receptors in the brain and parathyroid gland. Mol Pharmacol 36: 566-574, 1989.
110. Jin XH, Zhang JZ, Zhao YJ, Zhao RR. Localization of dopamine1A receptor mRNA in different vascular beds in rat: a nonradioactive in situ hybridization study. Methods Find Exp Clin Pharmacol 19: 657-663, 1997.
111. 2 receptor isoforms in cultured neurons reveals equipotent autoreceptor function. Neuropharmacology 50: 595-605, 2006.
112. 2-like receptors on renal function. Am J Physiol Regul Integr Comp Physiol 275: R986-R994, 1998.
113. Jose PA, Eisner GM, Drago J, Carey RM, Felder RA. Dopamine receptor signaling defects in spontaneous hypertension. Am J Hypertens 9: 400-405, 1996.
114. Jose PA, Eisner GM, Felder RA. Regulation of blood pressure by dopamine receptors. Nephron Physiol 95: 19-27, 2003.
115. 3 receptors. Neuroscience 112: 39-49, 2002.
116. 3 receptors. J Biol Chem 274: 29406-29412, 1999.
117. Kanterman RY, Mahan LC, Briley EM, Monsma FJ Jr, Sibley DR, Axelrod J, Felder CC. Transfected D2 dopamine receptors mediate the potentiation of arachidonic acid release in Chinese hamster ovary cells. Mol Pharmacol 39: 364-369, 1991.
118. Khundmiri SJ, Lederer E. PTH and DA regulate Na-K ATPase through divergent pathways. Am J Physiol Renal Physiol 282: F512-F522, 2002.
119. 2 receptor mRNAs in the rat systemic and pulmonary vasculatures. Mol Cell 9: 417-421, 1999.
120. Kinoshita S, Sidhu A, Felder RA. Defective dopamine-1 receptor adenylate cyclase coupling in the proximal convoluted tubule from the spontaneously hypertensive rat. J Clin Invest 84: 1849-1856, 1989.
121. +-ATPase activity in the proximal tubule. Am J Physiol Renal Physiol 292: F1435-F1442, 2007.
122. Kren V, Pravenec M, Lu S, Krenova D, Wang JM, Wang N, Merriouns T, Wong A, St Lezin E, Lau D, Szpirer C, Szpirer J, Kurtz TW. Genetic isolation of a region of chromosome 8 that exerts major effects on blood pressure and cardiac mass in the spontaneously hypertensive rat. J Clin Invest 99: 577-581, 1997.
123. Kruse MS, Adachi S, Scott L, Holtback U, Greengard P, Aperia A, Brismar H. Recruitment of renal dopamine 1 receptors requires an intact microtubulin network. Pflügers Arch 445: 534-539, 2003.
124. Krushkal J, Xiong M, Ferrell R, Sing CF, Turner ST, Boerwinkle E. Linkage and association of adrenergic and dopamine receptor genes in the distal portion of the long arm of chromosome 5 with systolic blood pressure variation. Hum Mol Genet 7: 1379-1383, 1998.
125. - cotransporter in rabbits and normotensive rats but not in spontaneously hypertensive rats. Kidney Int 57: 534-543, 2000.
126. 3 dopamine receptor-mediated regulation of spontaneous secretory activity. J Gen Physiol 115: 697-706, 2000.
127. 2-like dopamine receptor interaction in the spontaneously hypertensive rat. Am J Physiol Regul Integr Comp Physiol 281: R1071-R1078, 2001.
128. Lao YS, Hendley ED, Felder RA, Jose PA. Elevated renal cortical calmodulin- dependent protein kinase activity and blood pressure. Clin Exp Hypertens 24: 289-300, 2002.
129. Lederer ED, Sohi SS, McLeish KR. Dopamine regulates phosphate uptake by opossum kidney cells through multiple counter-regulatory receptors. J Am Soc Nephrol 9: 975-985, 1998.
130. 2 receptor. EMBO J 26: 2127-2136, 2007.
131. 1 receptor. Cell 111: 219-230, 2002.
132. 2 receptor co-activation generates a novel phospholipase C-mediated calcium signal. J Biol Chem 279: 35671-35678, 2004.
133. 3 receptors. FEBS Lett 439: 138-142, 1998.
134. 3 receptor functions? Biochem Pharmacol 52: 511-518, 1996.
135. +-ATPase. Am J Physiol Renal Fluid Electrolyte Physiol 269: F673-F680, 1995.
136. 1 receptor degradation (Abstract). FASEB J 20: A1285, 2006.
137. Li L, Schafer JA. Dopamine inhibits vasopressin-dependent cAMP production in the rat cortical collecting duct. Am J Physiol Renal Physiol 275: F62-F67, 1998.
138. Li XX, Bek M, Asico LD, Yang Z, Grandy DK, Goldstein DS, Rubinstein M, Eisner GM, Jose PA. Adrenergic and endothelin B receptor-dependent hypertension in dopamine receptor type-2 knockout mice. Hypertension 38: 303-308, 2001.
139. 2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites. Proc Natl Acad Sci USA 100: 4305-4309, 2003.
140. 5 and γ-aminobutyric acid A receptors. Nature 403: 274-280, 2000.
141. Lin JC, Tsao WL, Wang Y. Cardiovascular effects of NMDA in the RVLM of spontaneously hypertensive rats. Brain Res Bull 37: 289-294, 1995.
142. Lotharius J, O'Malley KL. The Parkinsonism-inducing drug 1-methyl-4- phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity. J Biol Chem 275: 38581-38588, 2000.
143. Lu Q, Asico LD, Jones JE, Bai R, Li H, Maines MD, Jose PA. Impaired heme oxygenase activity, increased reactive oxygen species, and high blood pressure in D5 dopamine receptor deficient mice (Abstract). J Am Soc Nephrol 16:163A, 2005.
144. 3 receptor activation modulates renal function in anesthetized rats. Naunyn Schmiedebergs Arch Pharmacol 358: 690-693, 1998.
145. 3 receptor activation in spontaneously hypertensive rats. Hypertens Res 26: 855-861, 2003.
146. 3 receptors and salt-dependent hypertension. J Am Soc Nephrol 12: 2272-2279, 2001.
147. Luo Y, Roth GS. The roles of dopamine oxidative stress and dopamine receptor signaling in aging and age-related neurodegeneration. Antioxid Redox Signal 2: 449-460, 2000.
148. Maeda Y, Terada Y, Nonoguchi H, Knepper MA. Hormone and autacoid regulation of cAMP production in rat IMCD subsegments. Am J Physiol Renal Fluid Electrolyte Physiol 263: F319-F327, 1992.
149. 2 heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropinirole. J Neurochem 87: 631-641, 2003.
150. Maiorov DN, Krenz NR, Krassioukov AV, Weaver LC. Role of spinal NMDA and AMPA receptors in episodic hypertension in conscious spinal rats. Am J Physiol Heart Circ Physiol 273: H1266-H1274, 1997.
151. 4 receptor. Mol Brain Res 29: 157-162, 1995.
152. Matsumoto T, Ozono R, Sasaki N, Oshima T, Matsuura H, Kajiyama G,
153. Michel MC, Siepmann F, Buscher R, Philipp T, Brodde OE. Ontogenesis of sympathetic responsiveness in spontaneously hypertensive rats. I. Renal alpha 1-, alpha 2-, and beta-adrenergic receptors and their signaling. Hypertension 22: 169-177, 1993.
154. Monsma FJ Jr, McVittie LD, Gerfen CR, Mahan LC, Sibley DR. Multiple D2 dopamine receptors produced by alternative RNA splicing. Nature 342: 926-929, 1989.
155. Muhlbauer B, Kuster E, Luippold G. Dopamine D3 receptors in the rat kidney: role in physiology and pathophysiology. Acta Physiol Scand 168: 219-223, 2000.
156. Murphy MB, Murray C, Shorten GD. Fenoldopam: a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension. N Engl J Med 345: 1548-1557, 2001.
157. Nakaki T, Nakayama M, Yamamoto S, Kato R. Alpha 1-adrenergic stimulation and beta 2-adrenergic inhibition of DNA synthesis in vascular smooth muscle cells. Mol Pharmacol 37: 30-36, 1989.
158. 2-like receptors causes recruitment of tyrosine-phosphorylated NKA α1-subunits in kidney. Am J Physiol Renal Physiol 283: F1290-F1295, 2002.
159. 2 receptor activation causes mitogenesis via p44/42 mitogen-activated protein kinase in opossum kidney cells. J Am Soc Nephrol 12: 1844-1852, 2001.
160. 1 dopamine receptor: expression of identical D1A and D1B dopamine receptor mRNAs in opossum kidney and brain. Mol Pharmacol 44: 918-925, 1993.
161. Nasjletti A. The role of eicosanoids in angiotensin-dependent hypertension. Hypertension 31: 194-200, 1998.
162. 5 dopamine receptor mediates big KCa channel activity in human coronary artery smooth muscle cells (Abstract). Hypertension 48: e80, 2006.
163. Nielsen CB, Pedersen EB. Abnormal distal tubular sodium reabsorption during dopamine infusion in patients with essential hypertension evaluated by the lithium clearance methods. Clin Nephrol 47: 304-309, 1997.
164. +-ATPase activity is lacking in Dahl salt-sensitive rats. Hypertension 21: 767-771, 1993.
165. 2 dopamine receptor gene with the receptor-binding characteristics in alcoholism. Arch Gen Psychiatry 48: 648-654, 1991.
166. 1 agonist in mouse cortical cell cultures. Exp Neurol 146: 604-608, 1997.
167. Nowicki S, Kruse MS, Brismar H, Aperia A. Dopamine-induced translocation of protein kinase C isoforms visualized in renal epithelial cells. Am J Physiol Cell Physiol 279: C1812-C1818, 2000.
168. 3 receptor in proximal tubules of the rat kidney. J Histochem Cytochem 52: 1647-1655, 2004.
169. O'Connell DP, Aherne AM, Lane E, Felder RA, Carey RM. Detection of dopamine receptor D1A subtype-specific mRNA in rat kidney by in situ amplification. Am J Physiol Renal Physiol 274: F232-F241, 1998.
170. 1A receptor protein in rat kidneys. Am J Physiol Renal Fluid Electrolyte Physiol 268: F1185-F1197, 1995.
171. O'Connell DP, Ragsdale NV, Boyd DG, Felder RA, Carey RM. Differential human renal tubular responses to dopamine type 1 receptor stimulation are determined by blood pressure status. Hypertension 29: 115-122, 1997.
172. 3 receptor protein in the rat kidney. Hypertension 32: 886-895, 1998.
173. Offen D, Ziv I, Sternin H, Melamed E, Hochman A. Prevention of dopamine-induced cell death by thiol antioxidants: possible implications for treatment of Parkinson's disease. Exp Neurol 141: 32-39, 1996.
174. Ohbu K, Felder RA. Nephron specificity of dopamine receptor-adenylyl cyclase defect in spontaneous hypertension. Am J Physiol Renal Fluid Electrolyte Physiol 264: F274-F279, 1993.
175. Ohbu K, Hendley ED, Yamaguchi I, Felder RA. Renal dopamine-1 receptors in hypertensive inbred rat strains with and without hyperactivity. Hypertension 21: 485-490, 1993.
176. Ominato Satoh MT, Katz AI. Regulation of Na-KATPase activity in the proximal tubule: role of the protein kinase C pathway and of eicosanoids. J Membr Biol 152: 235-243, 1996.
177. Osborn JW, Jacob F, Guzman P. A neural set point for the long-term control of arterial pressure: beyond the arterial baroreceptor reflex. Am J Physiol Regul Integr Comp Physiol 288: R846-R855, 2005.
178. 1 receptor protein in the human heart and kidney. Hypertension 30: 725-729, 1997.
179. Ozono R, Ueda A, Oishi Y, Yano A, Kambe M, Katsuki M, Oshima T. Dopamine D2 receptor modulates sodium handling via local production of dopamine in the kidney. J Cardiovasc Pharmacol 42: S75-S79, 2003.
180. - exchanger in immortalized SHR proximal tubular epithelial cells. Am J Physiol Renal Physiol 286: F1120-F1126, 2004.
181. 1 receptor function by physical interaction with the NMDA receptors. J Neurosci 24: 1149-1158, 2004.
182. 3 receptor gene polymorphisms, blood pressure and nephropathy in type 1 diabetic patients. Nephrol Dial Transplant 19: 1432-1436, 2004.
183. 2 receptor synergism. Nature 353: 164-167, 1991.
184. Polakowski JS, Segreti JA, Cox BF, Hsieh GC, Kolasa T, Moreland RB, Brioni JD. Effects of selective dopamine receptor subtype agonists on cardiac contractility and regional haemodynamics in rats. Clin Exp Pharmacol Physiol 31: 837-841, 2004.
185. Pollack A. Coactivation of D1 and D2 dopamine receptors: in marriage, a case of his, hers, and theirs. Sci STKE: pe50, 2004.
186. Premont RT, Gainetdinov RR. Physiological roles of G protein-coupled receptor kinases and arrestins. Annu Rev Physiol 69: 511-534, 2007.
187. Prinster SC, Hague C, Hall RA. Heterodimerization of G-proteincoupled receptors: specificity and functional significance. Pharmacol Rev 57: 289-298, 2005.
188. Ragsdale NV, Lynch M, Chevalier RL, Felder RA, Peach MJ, Carey RM. Selective peripheral dopamine-1 receptor stimulation: differential responses to sodium loading and depletion in humans. Hypertension 15: 914-921, 1990.
189. Raizada MK, Der Sarkissian S. Potential of gene therapy strategy for the treatment of hypertension. Hypertension 47: 6-9, 2006.
190. Rao GN, Berk BC. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ Res 70: 593-599, 1992.
191. Rao F, Wessel J, Wen G, Zhang L, Rana BK, Kennedy BP, Greenwood TA, Salem RM, Chen Y, Khandrika S, Hamilton BA, Smith DW, Holstein-Rathlou NH, Ziegler MG, Schork NJ, O'Connor DT. Renal albumin excretion: twin studies identify influences of heredity, environment, and adrenergic pathway polymorphism. Hypertension 49: 1015-1031, 2007.
192. Ricci A, Amenta F, Bronzetti E, Felici L, Hussain T, Lokhandwala MF. Age-related changes of dopamine receptor protein immunoreactivity in the rat mesenteric vascular tree. Mech Ageing Dev 123: 537-546, 2002.
193. Ricci A, Bronzetti E, Fedele F, Ferrante F, Zaccheo D, Amenta F. Pharmacological characterization and autoradiographic localization of a putative dopamine D4 receptor in the heart. J Auton Pharmacol 18: 115-121, 1998.
194. Ricci A, Collier WL, Amenta F. Pharmacological characterization and autoradiographic localization of dopamine receptors in the portal vein. J Auton Pharmacol 14: 61-68, 1994.
195. Ricci A, Marchal-Victorion S, Bronzetti E, Parini A, Amenta F, Tayebati SK. Dopamine D4 receptor expression in rat kidney: evidence for pre- and postjunctional localization. Histochem Cytochem 50: 1091-1096, 2002.
196. Ricci A, Mignini F, Tomassoni D, Amenta F. Dopamine receptor subtypes in the human pulmonary arterial tree. Auton Autacoid Pharmacol 26: 361-369, 2006.
197. Rice T, Rankinen T, Province MA, Chagnon YC, Perusse L, Borecki IB, Bouchard C, Rao DC. Genome-wide linkage analysis of systolic and diastolic blood pressure: the Quebec Family Study. Circulation 102: 1956-1963, 2000.
198. 3 receptors in islands of Calleja and shell of nucleus accumbens of the rat: opposite and synergistic functional interactions. Eur J Neurosci 10: 1676-1686, 1998.
199. Robinson SW, Caron MG. Selective inhibition of adenylyl cyclase type V by the dopamine D3 receptor. Mol Pharmacol 52: 508-514, 1997.
200. Rocheville M, Lange DC, Kumar U, Patel SC, Patel RC, Patel YC. Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science 288: 154-157, 2000.
201. 4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell 90: 991-1001, 1997.
202. Saito O, Ando Y, Kusano E, Asano Y. Functional characterization of basolateral and luminal dopamine receptors in rabbit CCD. Am J Physiol Renal Physiol 281: F114-F122, 2001.
203. 1-like receptor stimulation induces natriuresis via an angiotensin type-2 receptor mechanism. Hypertension 49: 155-161, 2007.
204. Sam EE, Verbeke N. Free radical scavenging properties of apomorphine enantiomers and dopamine: possible implication in their mechanism of action in Parkinsonism. J Neural Transm 10: 115-127, 1995.
205. Sanada H, Jose PA, Hazen-Martin D, Yu PY, Xu J, Bruns DE, Phipps J, Carey RM, Felder RA. Dopamine-1 receptor coupling defect in renal proximal tubule cells in hypertension. Hypertension 33: 1036-1042, 1999.
206. Sanada H, Xu J, Watanabe H, Jose PA, Felder RA. Differential expression and regulation of dopamine-1 (D-1) and dopamine-5 (D-5) receptor function in human kidney (Abstract). Am J Hypertens 13: 156A, 2000.
207. Sanada H, Yao L, Jose PA, Carey RM, Felder RA. Dopamine D3 receptors in rat juxtaglomerular cells. Clin Exp Hypertens 19: 93-105, 1997.
208. Sanada H, Yatabe J, Midorikawa S, Katoh T, Hashimoto S, Watanabe T, Xu J, Luo Y, Wang X, Zeng C, Armando I, Felder RA, Jose PA. Amelioration of genetic hypertension by suppression of renal G protein-coupled receptor kinase type 4 expression. Hypertension 47: 1131-1139, 2006.
209. Sarkis A, Lopez B, Roman RJ. Role of 20-hydroxyeicosatetraenoic acid and epoxy-eicosatrienoic acids in hypertension. Curr Opin Nephrol Hypertens 13: 205-214, 2004.
210. 1 receptor gene polymorphism is associated with essential hypertension. Hypertension 36: 183-186, 2000.
211. Satoh T, Cohen HT, Katz AI. Intracellular signaling in the regulation of renal Na-K-ATPase. I. Role of cyclic AMP and phospholipase A2. J Clin Invest 89: 1496-1500, 1992.
212. Satoh T, Cohen HT, Katz AI. Different mechanisms of renal Na-K-ATPase regulation by protein kinases in proximal and distal nephron. Am J Physiol Renal Fluid Electrolyte Physiol 265: F399-F405, 1993.
213. Sautel F, Griffon N, Levesque D, Pilon C, Schwartz JC, Sokoloff P. A functional test identifies dopamine agonists selective for D3 versus D2 receptors. Neuroreport 6: 329-332, 1995.
214. 3 dopamine receptor heterodimers exhibit unique functional properties. J Biol Chem 276: 30308-30314, 2001.
215. Schioth HB, Fredriksson R. The GRAFS classification system of G-protein coupled receptors in comparative perspective. Gen Comp Endocrinol 142: 94-101, 2005.
216. 3 receptors. J Biol Chem 275: 38944-38948, 2000.
217. 2 receptors. J Neurosci 22: 8002-8009, 2002.
218. 1 receptors in dendritic spines by NMDA receptor activation. Proc Natl Acad Sci USA 99: 1661-1664, 2002.
219. Sen S, Nesse R, Sheng L, Stoltenberg SF, Gleiberman L, Burmeister M, Weder AB. Association between a dopamine-4 receptor polymorphism and blood pressure. Am J Hypertens 18: 1206-1210, 2005.
220. Sheikh-Hamad D, Wang YP, Jo OD, Yanagawa N. Dopamine antagonizes the actions of angiotensin II in renal brush-border membrane. Am J Physiol Renal Fluid Electrolyte Physiol 264: F737-F743, 1993.
221. 2-like dopamine receptors in the kidney of the spontaneously hypertensive rat. J Hypertens 21: 199-207, 2003.
222. Shultz PJ, Sedor JR, Abboud HE. Dopaminergic stimulation of cAMP accumulation in cultured rat mesangial cells. Am J Physiol Heart Circ Physiol 253: H358-H364, 1987.
223. Sibley DR. New insights into dopaminergic receptor function using antisense and genetically altered animals. Annu Rev Pharmacol Toxicol 39: 313-341, 1999.
224. Soma M, Nakayama K, Rahmutula D, Uwabo J, Sato M, Kunimoto M, Aoi N, Kosuge K, Kanmatsuse K. Ser9Gly polymorphism in the dopamine D3 receptor gene is not associated with essential hypertension in the Japanese. Med Sci Monit 8: CR1-CR4, 2002.
225. 3 receptor knockout mice. Hypertens Res 30: 93-101, 2007.
226. Sugiyama F, Churchill GA, Higgins DC, Johns C, Makaritsis KP, Gavras H, Paigen B. Concordance of murine quantitative trait loci for salt-induced hypertension with rat and human loci. Genomics 71: 70-77, 2001.
227. 4 receptor isoform mRNA and protein are expressed in the rat cortical collecting duct. Am J Physiol Renal Physiol 275: F742-F751, 1998.
228. Sun MH, Ishine T, Lee TJ. Dopamine constricts porcine pial veins. Eur J Pharmacol 334: 165-167, 1997.
229. Sunahara RK, Guan HC, O'Dowd BF, Seeman P, Laurier LG, Ng G, George SR, Torchia J, Van Tol HH, Niznik HB. Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1. Nature 350: 614-619, 1991.
230. Takemoto F, Satoh T, Cohen HT, Katz AI. Localization of dopamine-1 receptors along the microdissected rat nephron. Pflügers Arch 419: 243-248, 1991.
231. Teirstein PS, Price MJ, Mathur VS, Madyoon H, Sawhney N, Baim DS. Differential effects between intravenous and targeted renal delivery of fenoldopam on renal function and blood pressure in patients undergoing cardiac catheterization. Am J Cardiol 97: 1076-1081, 2006.
232. 2 receptor and blood pressure in hyperglycaemic and normoglycaemic Chinese subjects. Clin Endocrinol (Oxf) 55: 605-611, 2001.
233. 2 receptor gene TaqI polymorphism. Hypertension 36: 177-182, 2000.
234. Touyz RM. Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II. Exp Physiol 90: 449-455, 2005.
235. Ueda A, Ozono R, Oshima T, Yano A, Kambe M, Teranishi Y, Katsuki M, Chayama K. Disruption of the type 2 dopamine receptor gene causes a sodium-dependent increase in blood pressure in mice. Am J Hypertens 16: 853-858, 2003.
236. 4 receptor variants in the human population. Nature 358: 149-152, 1992.
237. Wang H, Joseph JA. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic Biol Med 27: 612-616, 1999.
238. 3 deficient mice is associated with increased Na transporters in kidney (Abstract). J Am Soc Nephrol 16: 350A, 2005.
239. 1A receptor induces antinatriuresis in conscious rats. Hypertension 33: 504-510, 1999.
240. Wang ZQ, Siragy HM, Felder RA, Carey RM. Intrarenal dopamine production and distribution in the rat. Physiological control of sodium excretion. Hypertension 29: 228-234, 1997.
241. Watanabe H, Xu J, Bengra C, Jose PA, Felder RA. Desensitization of human renal D1 dopamine receptors by G protein-coupled receptor kinase 4. Kidney Int 62: 790-798, 2002.
242. 1 dopamine receptors and autoxidation. Mol Cell Neurosci 25: 124-137, 2004.
243. White BH, Kimura K, Sidhu A. Inhibition of hormonally induced inositol trisphosphate production in transfected GH4C1 cells: a novel role for the D5 subtype of the dopamine receptor. Neuroendocrinology 69: 209-216, 1999.
244. Ca channel activity in coronary artery smooth muscle cells. Circ Res 86: 897-905, 2000.
245. Wiederkehr MR, Di Sole F, Collazo R, Quinones H, Fan L, Murer H, Helmle-Kolb C, Moe OW. Characterization of acute inhibition of Na/H exchanger NHE-3 by dopamine in opossum kidney cells. Kidney Int 59: 197-209, 2001.
246. 1 receptor activation. J Neurochem 79: 63-70, 2001.
247. + exchanger interactions in the kidney in hypertension. Hypertension 36: 395-399, 2000.
248. 1A receptor gene in proximal tubule of rat kidneys. Am J Physiol Renal Fluid Electrolyte Physiol 264: F280-F285, 1993.
249. + ATPase activity in murine LTK2 cells. Mol Pharmacol 49: 373-378, 1996.
250. Yamaguchi I, Yao L, Sanada H, Ozono R, Mouradian MM, Jose PA, Carey RM, Felder RA. Dopamine D1A receptors and renin release in rat juxtaglomerular cells. Hypertension 29: 962-968, 1997.
251. Yamauchi M, Kobayashi Y, Shimoura K, Hattori K, Nakase A. Endothelium-dependent and -independent relaxation by dopamine in the rabbit pulmonary artery. Clin Exp Pharmacol Physiol 19: 401-410, 1992.
252. 5 dopamine receptor regulation of phospholipase D. Am J Physiol Heart Circ Physiol 288: H55-H61, 2005.
253. 5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure. Am J Physiol Regul Integr Comp Physiol 290: R96-R104, 2006.
254. Yao L, Ruan X, Arendshorst WJ, Jose PA. Dopamine receptor subtype (D1A and D1B) expression in rat renal microvessels (Abstract). Pediatr Res 37: 374A, 1995.
255. Yao LP, Huque E, Baraniuk J, Carey RM, Felder RA, Jose PA. Dopamine receptor subtype expression (D1A and D1B) in rat nephron segments (Abstract). J Investig Med 44: 305A, 1996.
256. 1 receptor and protein kinase C isoforms in spontaneously hypertensive rats. Hypertension 32: 1049-1053, 1998.
257. 1-like receptors. Arterioscler Thromb Vasc Biol 17: 3164-3173, 1997.
258. Yasunari K, Kohno M, Kano H, Minami M, Yoshikawa J. Dopamine as a novel antioxidative agent for rat vascular smooth muscle cells through dopamine D1-like receptors. Circulation 101: 2302-2308, 2000.
259. 1 dopamine receptor hyperphosphorylation in renal proximal tubules in hypertension. Kidney Int 70: 1072-1079, 2006.
260. 1 dopamine receptor signaling involves caveolin-2 in HEK-293 cells. Kidney Int 66: 2167-2180, 2004.
261. 3-preferring agonist (+)-PD 128907 on dialysate dopamine levels. Neuropharmacology 48: 43-50, 2005.
262. 4 receptors. J Thromb Haemost 4: 1588-1595, 2006.
263. 3 dopamine receptors in SHRs (Abstract). Am J Hypertens 17: 96A, 2004.
264. 3 dopamine receptors in renal proximal tubule cells of spontaneously hypertensive rats. Hypertension 41: 724-729, 2003.
265. 1 dopamine receptor function. Cardiovasc Hematol Agents Med Chem 4: 369-377, 2006.
266. 1 angiotensin receptor expression in rat renal proximal tubule cells. Circ Res 99: 494-500, 2006.
267. 1 receptor interaction in spontaneously hypertensive rats. Hypertension 42: 787-792, 2003.
268. Zeng C, Sanada H, Watanabe H, Eisner GM, Felder RA, Jose PA. Functional genomics of the dopaminergic system in hypertension. Physiol Genomics 19: 233-246, 2004.
269. 3 dopamine receptor transregulation in hypertension. Hypertension 43: 654-660, 2004.
270. 3 receptor action in rat aortic or mesenteric vascular smooth muscles. Hypertension 43: 673-679, 2004.
271. 1 dopamine receptors in immortalized renal proximal tubule cells. Hypertension 46: 799-805, 2005.
272. 1 dopamine receptor in immortalized renal proximal tubule cells. Hypertension 47: 573-579, 2006.
273. 5 dopamine receptors. Cardiovasc Hematol Agents Med Chem 5: 241-248, 2007.
274. 5 dopamine receptors in renal proximal tubule cells. Hypertension 45: 804-810, 2005.
275. 1 dopamine receptor in renal proximal tubule cells (Abstract). Am J Hypertens 15: 11A, 2002.
276. 3 dopamine receptor deficient mice. Zhonghua Xin Xue Guan Bing Za Zhi 33: 1132-1136, 2005.
277. Zhang H, Qiao Z, Zhao Y, Zhao R. Transcription of dopamine D1A receptor mRNAs in rat heart. Methods Find Exp Clin Pharmacol 18: 183-187, 1996.
278. Zhang J, Abdel-Rahman AA. The hypotensive action of rilmenidine is dependent on functional N-methyl-D-aspartate receptor in the rostral ventrolateral medulla of conscious spontaneously hypertensive rats. J Pharmacol Exp Ther 303: 204-210, 2002.
279. 3 receptors. J Neurosci 24: 3344-3354, 2004.
280. 13-protein subunit linkage of D5 dopamine receptors in the nephron. Hypertension 41: 604-610, 2003.